Skip to contentROSENWALD LINDSAY A MD — MANHATTAN PHARMACEUTICALS INC insider: 335 transactions · InsiderLensROSENWALD LINDSAY A MD
- 10% owner at CORDOVA SCIENCES, INC. · on record since Jan 31, 2006
- 10% owner at SEWARD SCIENCES, INC. · on record since Jan 31, 2006
- 10% owner at CHITINA SCIENCES, INC. · on record since Jan 31, 2006
- 10% owner at ARCTIC ACQUISITION CORP. · on record since Jan 31, 2006
- 10% owner at SITKA SCIENCES, INC. · on record since Jan 31, 2006
- 10% owner at KODIAK SCIENCES, INC. · on record since Jan 31, 2006
- 10% owner at KANAI SCIENCES, INC. · on record since Jan 31, 2006
- 10% owner at BRISTOL BAY SCIENCES, INC. · on record since Jan 31, 2006
- 10% owner at DENALI SCIENCES, INC. · on record since Jan 31, 2006
- 10% owner at NORTON SOUND ACQUISITION CORP. · on record since Jan 31, 2006
- Director at Paramount Acquisition Corp · on record since Jan 30, 2006
- Chairman of the Board at Paramount Acquisition Corp · on record since Jan 30, 2006
- 10% owner at NOVADEL PHARMA INC · on record since Jan 23, 2006
- 10% owner at ZIOPHARM ONCOLOGY INC · on record since Feb 13, 2006
- Director at KERYX BIOPHARMACEUTICALS INC · on record since May 24, 2006
- Director at SRKP 4 INC · on record since Apr 13, 2006
- 10% owner at SRKP 4 INC · on record since Apr 13, 2006
- 10% owner at KERYX BIOPHARMACEUTICALS INC · on record since Jun 9, 2006
- 10% owner at Innovive Pharmaceuticals, Inc. · on record since Jul 10, 2006
- 10% owner at JAVELIN PHARMACEUTICALS, INC · on record since Dec 28, 2006
- PRESIDENT, CEO & CHAIRMAN at Fortress Biotech, Inc. · on record since Apr 12, 2019
- 10% owner at GENTA INC DE/ · on record since Jul 10, 2003
- 10% owner at Fortress Biotech, Inc. · on record since Nov 17, 2011
- Director at Fortress Biotech, Inc. · on record since Sep 13, 2011
- 10% owner at MANHATTAN PHARMACEUTICALS INC · on record since Nov 17, 2003
- 10% owner at CYPRESS BIOSCIENCE INC · on record since Jan 13, 2004
- 10% owner at DOR BIOPHARMA INC · on record since Feb 17, 2004
- Director at CB Pharma Acquisition Corp. · on record since Dec 12, 2014
- Co-Chairman and CEO at CB Pharma Acquisition Corp. · on record since Dec 12, 2014
- 10% owner at CB Pharma Acquisition Corp. · on record since Dec 12, 2014
- 10% owner at NATIONAL HOLDINGS CORP · on record since Sep 22, 2016
- Director at Checkpoint Therapeutics, Inc. · on record since Oct 4, 2016
- Director at MUSTANG BIO, INC. · on record since Jul 20, 2017
- Director at AVENUE THERAPEUTICS, INC. · on record since Aug 18, 2017
- Director at Journey Medical Corp · on record since Jul 25, 2022
- 10% owner at Paramount Acquisition Corp · on record since Oct 21, 2005
Insider trading activity of ROSENWALD LINDSAY A MD
- Transactions on record
- 335
- since Sep 10, 2003
- Open-market buys
- 161
- $12M
- Open-market sells
- 25
- $1.2M
- Companies traded
- 16
- last filing Jun 26, 2026
Figures computed from official regulatory filings — methodology.
Companies where ROSENWALD LINDSAY A MD has traded
- Journey Medical Corp8 tx · $321.4K · Jun 26, 2026
- Fortress Biotech, Inc.72 tx · $10.7M · Mar 20, 2026
- Checkpoint Therapeutics, Inc.17 tx · $420.7K · May 30, 2025
- AVENUE THERAPEUTICS, INC.15 tx · $543.7K · Sep 25, 2024
- MUSTANG BIO, INC.16 tx · $810.3K · Jul 7, 2023
- CB Pharma Acquisition Corp.2 tx · Oct 13, 2015
- SRKP 4 INC7 tx · $10.1M · Jun 10, 2009
- Innovive Pharmaceuticals, Inc.1 tx · Feb 13, 2008
- Paramount Acquisition Corp21 tx · $540.4K · Feb 23, 2007
Track record of ROSENWALD LINDSAY A MD
Statistical track record
Free- Open-market buys
- 188
- Last buy
- Sep 23, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of ROSENWALD LINDSAY A MD
Co-insiders of ROSENWALD LINDSAY A MD
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
19 tx · Jan 23, 2007
WEISER MICHAELInnovive Pharmaceuticals, Inc. +5
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 26, 2026 | Award | 10,000 | 0.00 USD | — | SEC |
| Mar 20, 2026 | Award | 475,424 | 0.00 USD | $0 | SEC |
| Aug 7, 2025 | Award | 50,000 | 0.00 USD | $0 | SEC |
| Jul 7, 2025 | Award | 7,173 | 0.00 USD | $0 | SEC |
| May 30, 2025 | Award | 50,000 | 1.29 USD | $64.5K | SEC |
| May 30, 2025 | Other | -207,007 | — | — | SEC |
| May 30, 2025 | Award | 12,195 | 0.00 USD | $0 | SEC |
| Jan 3, 2025 | Award | 454,153 | 0.00 USD | $0 | SEC |
| Dec 17, 2024 | Award | 12,638 | 0.00 USD | $0 | SEC |
| Sep 25, 2024 | BuyD | 763,359 | 0.13 USD | $99.2K | SEC |
| Sep 25, 2024 | Buy | 763,359 | 1.84 USD | $1.4M | SEC |
| Sep 25, 2024 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Jul 15, 2024 | Buy | 5,000 | 7.48 USD | $37.4K | SEC |
| Jul 11, 2024 | Buy | 5,000 | 7.39 USD | $37K | SEC |
| Jul 10, 2024 | Buy | 5,000 | 7.35 USD | $36.8K | SEC |
| Jul 10, 2024 | Award | 9,728 | 0.00 USD | $0 | SEC |
| Jul 1, 2024 | Buy | 20,000 | 1.64 USD | $32.8K | SEC |
| May 20, 2024 | Buy | 10,000 | 1.76 USD | $17.6K | SEC |
| May 16, 2024 | Award | 32,051 | 0.00 USD | $0 | SEC |
| May 16, 2024 | Award | 50,000 | 0.00 USD | $0 | SEC |
| Mar 27, 2024 | Buy | 10,000 | 3.04 USD | $30.4K | SEC |
| Mar 25, 2024 | Buy | 20,000 | 3.40 USD | $68K | SEC |
| Jan 9, 2024 | Buy | 50,000 | 2.38 USD | $119K | SEC |
| Jan 3, 2024 | Award | 216,465 | 0.00 USD | $0 | SEC |
| Nov 16, 2023 | Buy | 1,567,515 | 1.70 USD | $2.7M | SEC |